SOURCE: Protagen AG

September 19, 2006 05:00 ET

Protagen Strengthens Its Management Team

DORTMUND, GERMANY -- (MARKET WIRE) -- September 19, 2006 -- Protagen AG, the developer and producer of protein biochips, assigned the management of the newly formed business unit Protein Biochips to Jens Beator, PhD.

Jens Beator (43) has more than ten years of experience in the biotechnology business, gained during his employment at Whatman, formerly Schleicher & Schuell BioScience. As director of Business Development Protein Arrays Europe, he was decisively responsible for the expansion of the European sales. Prior to this, he was significantly involved into the business expansion on the Asian market. His main focus was on clients from industry and academia. Jens Beator initialized several scientific cooperations in clinical research and in in-vitro diagnostics, opening new markets for protein biochips.

Within Protagen AG Jens Beator is now responsible for the technical development of the UNIchip® family, introduced into the market in September 2005. He will be assisted by a team of eight scientists and well-trained technicians.

Beator was born in Lower Saxony, Germany, and studied biology in Boston and Hanover, Germany, and passed his diploma as well as his PhD at the institute of botany with distinction. He started his professional career as product manager at Schleicher & Schuell, prior to his occupation for the sales department of Biometra and Thermo Shandon (1999 until 2001).

Reproduction of the photograph is free of charge.

About Protagen AG

Protagen AG is an internationally operating biotech company active in nanobiotechnology with a specialization in proteins. It was founded in 1997 and is based in Dortmund, Germany. The fields of activity are protein analysis, information technologies to support it, protein production, and the production of protein biochips. The products and services are marketed and sold directly to the end user in research and development in the life sciences industries. In the future the attractive diagnostic market will be addressed. Currently, the most successful product line is the biochip family UNIchip®, designed for faster development of diagnostic and therapeutic antibodies. The consistent focus of Protagen AG on high quality products and services as well as the excellent internal know how, has led the company to a market position based on technology leadership.

Protagen AG, since 2002, is located in the BioMedizinZentrum Dortmund occupying more than 15.000 square feet of office and laboratory space. Protagen AG employs currently 32 people.

About UNIchip®

The brand name UNIchip® of Protagen AG comprises a new proprietary class of protein biochips. These products can be produced in a tailor-made fashion. Their use simplify and accelerate the development of new biological entities (NBEs) like antibodies as new therapeutics.

Further information can be found on the company web site www.protagen.com.

Contact Information

  • Contact
    Dr. Christoph Hüls
    CEO
    Protagen AG
    Otto-Hahn-Str. 15
    44227 Dortmund
    Germany
    Tel: +49 (0) 231 9742 6300
    Fax: +49 (0) 231 9742 6301
    E-Mail: Email Contact